Will Medicare Cover Ozempic or Wegovy in 2026? What Retirees Need to Know About GLP-1 Coverage

Source The Motley Fool

Key Points

  • Medicare currently covers GLP-1s to treat conditions like Type 2 diabetes.

  • It will begin covering the drug for weight loss with prior authorization beginning in July 2026.

  • It'll be up to Part D plan providers to decide whether to cover the drug in 2027 and beyond.

  • The $23,760 Social Security bonus most retirees completely overlook ›

Medicare beneficiaries are reaping the benefits of negotiated rates on 10 popular prescription drugs this year, but there are some notable absences on that list, specifically GLP-1 medications. Though these drugs have become extremely popular for weight loss, Medicare doesn't currently cover them for this purpose.

Fortunately, we're only a few months away from a shift that will make these medications a lot more accessible to you if you're on Medicare. Here's what you need to know.

Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »

Older patient talking to a doctor.

Image source: Getty Images.

Medicare doesn't currently cover GLP-1s for weight loss

Medicare currently covers drugs like Ozempic and Wegovy for specific purposes, like managing Type 2 diabetes. If you have a condition like this, you may be able to get one of these medications under your Medicare Part D plan right away.

But if you just want a GLP-1 to help you lose weight, you're out of luck for the moment. Medicare doesn't cover these drugs for weight loss purposes, so you'll either need to cover them out of pocket -- which can cost almost $1,000 per month -- or use another health insurance plan if you have one available.

Fortunately, all that will change in a few months. Medicare is changing its rules for GLP-1 coverage, and this could give some beneficiaries access to the drugs for weight loss as soon as July 2026.

Medicare will start covering GLP-1s for weight loss later this year

Medicare is launching the Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth (BALANCE) model in January 2027. Under this model, you'll be able to get coverage for GLP-1s on some Medicare Part D plans next year. However, it'll be up to each private health insurer offering the Part D plans to decide whether to include this coverage.

Beginning in July 2026, Medicare will begin offering a GLP-1 bridge to give beneficiaries earlier access to these medications. To be eligible, you must have a Medicare Part D plan or a Medicare Advantage plan that includes prescription drug coverage. You'll also need your healthcare provider to submit a prior authorization form to Medicare.

If you have any questions, consider reaching out to the Center for Medicare & Medicaid Services or your Part D plan administrator for clarification. You'll also want to pay careful attention to which Part D plan you choose during the next Open Enrollment Period. If you opt for a plan without GLP-1 coverage, your retirement healthcare costs could skyrocket in 2027.

The $23,760 Social Security bonus most retirees completely overlook

If you're like most Americans, you're a few years (or more) behind on your retirement savings. But a handful of little-known "Social Security secrets" could help ensure a boost in your retirement income.

One easy trick could pay you as much as $23,760 more... each year! Once you learn how to maximize your Social Security benefits, we think you could retire confidently with the peace of mind we're all after. Join Stock Advisor to learn more about these strategies.

View the "Social Security secrets" »

The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Natural Gas sinks to pivotal level as China’s demand slumpsNatural Gas price (XNG/USD) edges lower and sinks to $2.56 on Monday, extending its losing streak for the fifth day in a row. The move comes on the back of China cutting its Liquified Natural Gas (LNG) imports after prices rose above $3.0 in June. It
Author  FXStreet
Jul 01, 2024
Natural Gas price (XNG/USD) edges lower and sinks to $2.56 on Monday, extending its losing streak for the fifth day in a row. The move comes on the back of China cutting its Liquified Natural Gas (LNG) imports after prices rose above $3.0 in June. It
placeholder
The dollar weakened, equities dipped, and gold hit record highsThe dollar weakened, equities fell, and gold set new records on Wednesday as investors waited for a Fed rate cut later in the day.
Author  Cryptopolitan
Sep 17, 2025
The dollar weakened, equities fell, and gold set new records on Wednesday as investors waited for a Fed rate cut later in the day.
placeholder
Pi Network Price Annual Forecast: PI Heads Into a Volatile 2026 as Utility Questions Collide With Big UnlocksPi Network heads into 2026 after a 90%+ 2025 drawdown from $3.00, with 17.5 million KYC users and a smart-contract-focused Stellar v23 upgrade offering upside potential, but 1.21 billion tokens unlocking and heavy exchange deposits (437 million PI) keeping supply pressure and trust risks firmly in focus.
Author  Mitrade
Dec 19, 2025
Pi Network heads into 2026 after a 90%+ 2025 drawdown from $3.00, with 17.5 million KYC users and a smart-contract-focused Stellar v23 upgrade offering upside potential, but 1.21 billion tokens unlocking and heavy exchange deposits (437 million PI) keeping supply pressure and trust risks firmly in focus.
placeholder
Markets in 2026: Will gold, Bitcoin, and the U.S. dollar make history again? — These are how leading institutions thinkAfter a turbulent 2025, what lies ahead for commodities, forex, and cryptocurrency markets in 2026?
Author  Insights
Dec 25, 2025
After a turbulent 2025, what lies ahead for commodities, forex, and cryptocurrency markets in 2026?
placeholder
ECB Policy Outlook for 2026: What It Could Mean for the Euro’s Next MoveWith the ECB likely holding rates steady at 2.15% and the Fed potentially extending cuts into 2026, EUR/USD may test 1.20 if Eurozone growth proves resilient, but weaker growth and an ECB pivot could pull the pair back toward 1.13 and potentially 1.10.
Author  Mitrade
Dec 26, 2025
With the ECB likely holding rates steady at 2.15% and the Fed potentially extending cuts into 2026, EUR/USD may test 1.20 if Eurozone growth proves resilient, but weaker growth and an ECB pivot could pull the pair back toward 1.13 and potentially 1.10.
goTop
quote